CHO Pharma, Inc. (TPEX:6586)

CHO Pharma Revenue

CHO Pharma had revenue of 986.00K TWD in the half year ending June 30, 2026, a decrease of -8.87%. This brings the company's revenue in the last twelve months to 1.71M, down -46.88% year-over-year. In the year 2025, CHO Pharma had annual revenue of 1.43M, down -60.03%. That makes CHO Pharma the 46,486th largest company in the world by revenue and 2,197th in Taiwan.

• Revenue (ttm): 1.71M
• Revenue Growth: -46.88%
• P/S Ratio: 14,497.49
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 24.50B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.43M	-2.15M	-60.03%
Dec 31, 2024	3.58M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	60.00K	-3.51M	-98.32%
Dec 31, 2021	3.57M	3.43M	2,486.96%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 8, 2026

Data Sources Report a data error